This inventor holds 2 USPTO granted patents and 4 EPO patents. Top assignee: Molecure S.a.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Adam Golebiowski: Innovator in Therapeutics
Introduction
Adam Golebiowski is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of therapeutics, particularly through his innovative work on deubiquitinase inhibitors.
Latest Patents
Golebiowski holds 1 patent for his invention titled "Deubiquitinase inhibitors and methods of use thereof." This inventive compound consists of small molecule therapeutics that are potent inhibitors of USP7 activity. The invention also includes pharmaceutical compositions comprising these compounds, along with methods for using them to treat or prevent diseases, disorders, or conditions associated with USP7 activity.
Career Highlights
Throughout his career, Adam Golebiowski has worked with various companies, including Molecure S.A. and Oncoarendi Therapeutics S.A. His work has focused on developing innovative solutions in the therapeutic landscape.
Collaborations
Golebiowski has collaborated with notable coworkers such as Jacek Chrzanowski and Julita Nowicka, contributing to advancements in his field.
Conclusion
Adam Golebiowski's work in developing deubiquitinase inhibitors showcases his commitment to advancing therapeutic options. His contributions are significant in the ongoing quest for effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile